These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4123994)

  • 1. Immunologic release of chemical mediators from human nasal polyps.
    Kaliner M; Wasserman SI; Austen KF
    N Engl J Med; 1973 Aug; 289(6):277-81. PubMed ID: 4123994
    [No Abstract]   [Full Text] [Related]  

  • 2. Symposium on allergic lung disease. IV. Immunologic mechanisms for release of chemical mediators of anaphylaxis from human lung tissue.
    Kaliner M
    Can Med Assoc J; 1974 Feb; 110(4):431 passim. PubMed ID: 4134081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction mechanisms in the release of mediators of immediate hypersensitivity from human lung tissue.
    Austen KF
    Fed Proc; 1974 Nov; 33(11):2256-62. PubMed ID: 4139041
    [No Abstract]   [Full Text] [Related]  

  • 4. Current concepts of immediate (reaginic) hypersensitivity.
    Evans R
    Med Ann Dist Columbia; 1972 Jul; 41(7):427-30. PubMed ID: 4114830
    [No Abstract]   [Full Text] [Related]  

  • 5. The immunological basis of immediate hypersensitivity.
    Cooper DA
    Aust Fam Physician; 1979 Jan; 8(1):38-9, 41-3, 45-6. PubMed ID: 86347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotaxis of eosinophil leukocytes in relation to immediate-type hypersensitivity and the complement system.
    Kay AB
    Antibiot Chemother (1971); 1974; 19():271-83. PubMed ID: 4142850
    [No Abstract]   [Full Text] [Related]  

  • 7. The release of four mediators of immediate hypersensitivity from human leukemic basophils.
    Lewis RA; Goetzl EJ; Wasserman SI; Valone FH; Rubin RH; Austen KF
    J Immunol; 1975 Jan; 114(1 Pt 1):87-92. PubMed ID: 46247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung.
    Kaliner M; Orange RP; Austen KF
    J Exp Med; 1972 Sep; 136(3):556-67. PubMed ID: 4115132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human lung tissue and anaphylaxis. Evidence that cyclic nucleotides modulate the immunologic release of mediators through effects on microtubular assembly.
    Kaliner M
    J Clin Invest; 1977 Oct; 60(4):951-9. PubMed ID: 197128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the immunological release of the eosinophil chemotactic factor of anaphylaxis from human lung.
    Wasserman SI; Goetzl EJ; Kaliner M; Austen KF
    Immunology; 1974 Apr; 26(4):677-84. PubMed ID: 4137063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic inhibition of the antigen-induced release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE.
    Ishizaka T; Ishizaka K; Orange RP; Austen KF
    J Immunol; 1971 May; 106(5):1267-73. PubMed ID: 4102404
    [No Abstract]   [Full Text] [Related]  

  • 12. The immediate allergic response: in vitro action of cyclic AMP-active and other drugs on the two stages of histamine release.
    Lichtenstein LM; DeBernardo R
    J Immunol; 1971 Oct; 107(4):1131-6. PubMed ID: 4106092
    [No Abstract]   [Full Text] [Related]  

  • 13. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.
    Kay AB; Austen KF
    J Immunol; 1971 Sep; 107(3):899-902. PubMed ID: 4105937
    [No Abstract]   [Full Text] [Related]  

  • 14. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity.
    Goetzl EJ; Wasserman SI; Austen F
    Arch Pathol; 1975 Jan; 99(1):1-4. PubMed ID: 234219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic anaphylaxis in the human being.
    Austen KF
    N Engl J Med; 1974 Sep; 291(13):661-4. PubMed ID: 4137227
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.
    Orange RP; Austen WG; Austen KF
    J Exp Med; 1971 Sep; 134(3 Pt 2):136s-148s. PubMed ID: 4105807
    [No Abstract]   [Full Text] [Related]  

  • 17. Release of slow reacting substance of anaphylaxis from human leukocytes.
    Grant JA; Lichtenstein LM
    J Immunol; 1974 Mar; 112(3):897-904. PubMed ID: 4130114
    [No Abstract]   [Full Text] [Related]  

  • 18. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis.
    Kramer MF; Ostertag P; Pfrogner E; Rasp G
    Laryngoscope; 2000 Jun; 110(6):1056-62. PubMed ID: 10852530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cell activation markers in rhinitis and rhinosinusitis. 1: Eosinophilic cationic protein (ECP)].
    Klimek L; Rasp G
    Laryngorhinootologie; 1996 Nov; 75(11):665-70. PubMed ID: 9063834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique modulation of the immunological release of slow-reacting substance of anaphylaxis (SRS-A) from bovine lung.
    Burka JF; Eyre P
    Monogr Allergy; 1977; 12():241-4. PubMed ID: 335217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.